Skip to Main Content

Paper Details

Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404).
J Clin Oncol
22
2022
Author NameAffiliation
Alan L HoMemorial Sloan Kettering Cancer Center
Alan L HoWeill Cornell Medical College
Katharine A PriceMayo Clinic
Hyunseok KangUniversity of California at San Francisco
Eric J ShermanMemorial Sloan Kettering Cancer Center
Eric J ShermanWeill Cornell Medical College
Luc G T MorrisMemorial Sloan Kettering Cancer Center
Nora KatabiMemorial Sloan Kettering Cancer Center
Nora KatabiWeill Cornell Medical College
  • 1 - 9

Datasets

Release 1.2